Eagle Pharmaceuticals
EGRX
#10473
Rank
HK$30.24 M
Marketcap
HK$2.33
Share price
36.36%
Change (1 day)
-48.23%
Change (1 year)

Market capitalization of Eagle Pharmaceuticals (EGRX)

Market cap: HK$30.24 Million

As of December 2025 Eagle Pharmaceuticals has a market cap of HK$30.24 Million. This makes Eagle Pharmaceuticals the world's 10473th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eagle Pharmaceuticals from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025HK$30.24 M-45.35%
2024HK$55.33 M-89.57%
2023HK$0.53 B-82.15%
2022HK$2.97 B-42.03%
2021HK$5.12 B9%
2020HK$4.70 B-26.24%
2019HK$6.37 B45.28%
2018HK$4.38 B-29.51%
2017HK$6.22 B-34.59%
2016HK$9.52 B-11.4%
2015HK$10.74 B536.79%
2014HK$1.68 B

End of Day market cap according to different sources

On Dec 21st, 2025 the market cap of Eagle Pharmaceuticals was reported to be:

N/A
by Nasdaq info icon info icon
HK$22.17 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
HK$3.867 T 12,789,876.18%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$765.72 B 2,531,972.06%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
HK$2.030 T 6,715,604.10%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Teva Pharmaceutical Industries
TEVA
HK$270.86 B 895,599.37%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
HK$1.371 T 4,534,671.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$7.471 T 24,707,488.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$858.16 B 2,837,671.35%๐Ÿ‡บ๐Ÿ‡ธ USA